12.1
Katherine Unger Baillie
Science News Officer
kbaillie@upenn.edu
Cancer Research
Researchers identify method to slow down cancer cells efforts to multiply
Researchers identify method to slow down cancer cells efforts to multiply
A study from the Abramson Cancer Center finds that turning on a key metabolic process could make soft tissue sarcoma more susceptible to treatment.
Kill stomach cancer risk by attacking this common bacteria
Kill stomach cancer risk by attacking this common bacteria
Penn researchers are the first to assess Helicobacter pylori infection and gastric cancer risk among certain demographics and ethnic groups.
Positive results in first-in-U.S. trial of CRISPR-edited immune cells
Positive results in first-in-U.S. trial of CRISPR-edited immune cells
Genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology, then infusing those cells back into the patient appears safe and feasible based on early data from the first-ever clinical trial to test the approach in humans in the United States.
To monitor cancer therapy, researchers tag CAR T cells with imaging markers
To monitor cancer therapy, researchers tag CAR T cells with imaging markers
With CAR T cell therapy, a patient’s own immune cells are genetically modified and inserted back into the body to find and kill cancer. Now scientists have now discovered a new way to track CAR T cells in the body.
Blood test can predict prognosis in deadly brain cancer
Blood test can predict prognosis in deadly brain cancer
A Penn study points to clinical utility of liquid biopsy in glioblastoma, allowing doctors the ability to measure the progression of the cancer based on the amount of cell-free DNA in the bloodstream
Algorithm identifies advance care planning needs
Algorithm identifies advance care planning needs
A Penn-developed system can be used to ensure that doctors talk to cancer patients about their values and goals before it is too late.
Basser Center takes aim at BRCA
Basser Center takes aim at BRCA
Twenty-five years after the discovery of genetic mutations that dramatically increase cancer risk, the Penn Medicine’s Basser Center for BRCA is building scientific knowledge alongside public awareness about BRCA-related cancers.
Algorithm personalizes which cancer mutations are best targets for immunotherapy
Algorithm personalizes which cancer mutations are best targets for immunotherapy
A new model developed by researchers in the Abramson Cancer Center hand-picks cancer cells to target for more effective, customized cancer vaccines.
In pursuit of a cure, when ideas and options have run out
In pursuit of a cure, when ideas and options have run out
A new book from Penn Medicine’s David Fajgenbaum chronicles his journey to beat Castleman disease, a rare disorder that he’s lived with for almost a decade.
Two studies highlight proton therapy for pediatric brain cancer
Two studies highlight proton therapy for pediatric brain cancer
A pair of new studies done at Penn and the Children’s Hospital of Philadelphia add to the growing body of research showing the potential benefits of proton therapy.
Media Contact
Experts
In the News
HealthDay News
For Breast Cancer Patients, Less Time on Hormonal Meds?
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Nature
Acupuncture in Cancer Study Reignites Debate About Controversial Technique
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →